Table 4.
Preference choice modelling results (summary of differences by country, age and gender)
| Model parameter | Differences by country | Differences by age and gender | ||
|---|---|---|---|---|
| Stronger preference or weaker aversion compared with the baseline group a | Weaker preference or stronger aversion compared with the baseline group a | Stronger preference or weaker aversion compared with the baseline group a (coefficient) | Weaker preference or stronger aversion compared with the baseline group a (coefficient) | |
| Information stored | ||||
| Basic health status | Czech Republic (0.19) | United Kingdom (−0.11) | 18–24 (0.28) | |
| Lithuania (0.25) | ||||
| [information above +] identification | 18–24 (0.23) | |||
| [information above +] lifelong health conditions | 18–24 (0.29) | 55–64 (−0.09) | ||
| 25–34 (0.10) | ||||
| [information above +] all other health conditions and medical history | Cyprus (0.72) | Men (0.06) | ||
| 18–24 (0.42) | ||||
| 25–34 (0.18) | ||||
| Access (personnel) | ||||
| Only doctors and nurses | Slovenia (0.30) | |||
| Doctors, nurses, and paramedics | Estonia (0.24) | |||
| Doctors, nurses, paramedics, and fire and rescue | Denmark (−0.11) | 65+ (−0.11) | ||
| Access (location) | ||||
| Only in the home country | Czech Republic (0.18) | Belgium (−0.25) | 65+(0.13) | |
| Slovakia (0.11) | Ireland (−0.19) | |||
| Romania (−0.34) | ||||
| Spain (−0.25) | ||||
| Across Europe (EU) | Austria (−0.21) | |||
| Worldwide | Slovakia (−0.10) | 18–24 (0.11) | 65+ (−0.098) | |
| 25–34 (0.14) | ||||
| Sharing | ||||
| No one | Austria (0.21) | Lithuania (−0.43) | ||
| Luxembourg (0.21) | Romania (−0.39) | |||
| Netherlands (0.27) | Slovakia (−0.19) | |||
| Immediate family | Slovenia (0.52) | |||
| Nurses providing home care | Belgium (0.17) | Bulgaria (−0.24) | ||
| Slovakia (−0.27) | ||||
| France (0.21) | Lithuania (−0.31) | |||
| Health insurance companies | Czech Republic (0.20) | France (−0.40) | ||
| Latvia (0.36) | Greece (–0.53) | |||
| Slovakia (0.19) | Italy (−0.29) | |||
| Hungary (0.22) | ||||
| Ireland (−0.24) | ||||
| UK (−0.25) | ||||
| Private sector pharmaceutical companies | Bulgaria (0.35) | Austria (−0.23) | ||
| Hungary (0.41) | Belgium (−0.20) | |||
| Latvia (0.47) | Denmark (−0.14) | |||
| Lithuania (0.22) | Estonia (−0.25) | |||
| Portugal (0.36) | Germany (−0.47) | |||
| Romania (0.46) | Luxembourg (−1.56) | |||
| Slovakia (0.21) | Slovenia (−0.32) | |||
| Academic researchers (if your name is not connected to the data) | Estonia (0.36) | Romania (−0.23) | ||
| Denmark (0.33) | ||||
a In all analyses, differences in preferences for each country, age group, and gender were tested. Where differences did occur, the group was modelled separately for that particular preference and these differences are presented in this table.